MedPath

IODIXANOL INJECTION 270

IODIXANOL INJECTION 270

Approved
DIN Number

02553953

Drug Class

Human

Market Date

May 29, 2025

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02553953
AIG Number0126988001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08AB09 IODIXANOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntra-Arterial ,  Intravenous
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IODIXANOLActive
Strength: 550 MG / ML
Monograph: IODIXANOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.